Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years

The observational CERTITUDE study follows liver transplant patients who completed the SIMCER trial. SIMCER randomized patients at month 1 after transplant to everolimus (EVR) with stepwise tacrolimus (TAC) withdrawal or to standard TAC, both with basiliximab induction and mycophenolic acid ± steroid...

Descripción completa

Detalles Bibliográficos
Autores principales: Saliba, Faouzi, Duvoux, Christophe, Dharancy, Sébastien, Dumortier, Jérôme, Calmus, Yvon, Gugenheim, Jean, Kamar, Nassim, Salamé, Ephrem, Neau‐Cransac, Martine, Vanlemmens, Claire, Durand, François, Pageaux, Georges, Leroy, Vincent, Hardwigsen, Jean, Gharbi, Hakam, Masson, Cécile, Tindel, Malka, Conti, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383505/
https://www.ncbi.nlm.nih.gov/pubmed/31631501
http://dx.doi.org/10.1002/lt.25664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383505/
https://www.ncbi.nlm.nih.gov/pubmed/31631501
http://dx.doi.org/10.1002/lt.25664

Ejemplares similares